Stereotactic Liver Ablation Assisted With Intra-Arterial CT Hepatic Arteriography and Ablation Confirmation Software Assessment (STEREOLAB)
Not Applicable
Recruiting
- Conditions
- HepaticLiver Ablation
- Interventions
- Procedure: Liver ablation
- First Posted Date
- 2022-05-04
- Last Posted Date
- 2024-03-22
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 50
- Registration Number
- NCT05361551
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
A Phase I-II Study Investigating the All Oral Combination of the Menin Inhibitor SNDX-5613 With Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE)
Phase 1
Recruiting
- Conditions
- Acute Myeloid Leukemia
- Interventions
- First Posted Date
- 2022-05-04
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 43
- Registration Number
- NCT05360160
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides
- First Posted Date
- 2022-05-03
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT05357794
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique
Phase 2
Recruiting
- Conditions
- Cervical Cancer
- Interventions
- Behavioral: HPV testing of women for cervical cancer screening
- First Posted Date
- 2022-05-03
- Last Posted Date
- 2024-11-11
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 14600
- Registration Number
- NCT05359016
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients Relapsed/Refractory Hodgkin's Lymphoma
- First Posted Date
- 2022-05-02
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 24
- Registration Number
- NCT05355051
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
Innovative Treatment of Chemotherapy-Induced Painful Peripheral Neuropathy in Adolescents and Young Adults With Cancer: A Two Arm Pilot Study
Not Applicable
Recruiting
- Conditions
- Peripheral Neuropathy
- Interventions
- Device: Waitlist ST (Scrambler Therapy)Device: Immediate St (Scrambler Therapy)
- First Posted Date
- 2022-05-02
- Last Posted Date
- 2024-07-01
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 38
- Registration Number
- NCT05357469
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
The Effects of Spiritual Needs on Spiritual Well-Being in Patients With Brain Tumors: A Structural Equation Modeling Approach
Withdrawn
- Conditions
- Brain Tumor
- First Posted Date
- 2022-05-02
- Last Posted Date
- 2023-02-02
- Lead Sponsor
- M.D. Anderson Cancer Center
- Registration Number
- NCT05356507
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Phase II Trial of Immunotherapy in Patients with Carcinomas Arising from the Renal Medulla
Phase 2
Active, not recruiting
- Conditions
- CarcinomasRenal Medullary Carcinoma
- Interventions
- First Posted Date
- 2022-04-26
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT05347212
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
TAS-102 in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy
- First Posted Date
- 2022-04-25
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 25
- Registration Number
- NCT05343013
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
A Comprehensive Clinical FMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain
Recruiting
- Conditions
- Brain Tumor
- First Posted Date
- 2022-04-22
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 1720
- Registration Number
- NCT05342454
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath